indocin
| Product dosage: 25mg | |||
|---|---|---|---|
| Package (num) | Per pill | Price | Buy |
| 90 | $0.50 | $45.21 (0%) | 🛒 Add to cart |
| 180 | $0.40 | $90.42 $72.33 (20%) | 🛒 Add to cart |
| 270 | $0.37 | $135.62 $99.46 (27%) | 🛒 Add to cart |
| 360 | $0.35
Best per pill | $180.83 $125.58 (31%) | 🛒 Add to cart |
| Product dosage: 50mg | |||
|---|---|---|---|
| Package (num) | Per pill | Price | Buy |
| 60 | $0.82 | $49.23 (0%) | 🛒 Add to cart |
| 90 | $0.69 | $73.84 $62.29 (16%) | 🛒 Add to cart |
| 120 | $0.62 | $98.45 $74.34 (24%) | 🛒 Add to cart |
| 180 | $0.55 | $147.68 $98.45 (33%) | 🛒 Add to cart |
| 270 | $0.51 | $221.52 $137.63 (38%) | 🛒 Add to cart |
| 360 | $0.49
Best per pill | $295.36 $175.81 (40%) | 🛒 Add to cart |
Indocin, known generically as indomethacin, is a potent nonsteroidal anti-inflammatory drug (NSAID) that’s been a workhorse in clinical practice for decades. It’s primarily used for its powerful anti-inflammatory, analgesic, and antipyretic properties. Unlike many newer agents, indomethacin has a broad spectrum of applications, from acute gouty arthritis to closing a patent ductus arteriosus in neonates. Its significance lies in its potency; when other NSAIDs like ibuprofen or naproxen fall short, indomethacin often delivers the therapeutic punch needed. We initially viewed it as just another NSAID, but its unique profile and specific indications make it a cornerstone in certain clinical scenarios.
Key Components and Bioavailability of Indocin
Indocin’s active pharmaceutical ingredient is indomethacin. It’s available in several formulations: immediate-release capsules (25 mg, 50 mg), sustained-release capsules (75 mg), oral suspension (25 mg/5mL), and suppositories (50 mg). The bioavailability is nearly 100% for the oral forms, but food can delay the absorption rate, something we always counsel patients on. The sustained-release form is particularly useful for conditions requiring round-the-clock inflammation control, like ankylosing spondylitis. We had a huge debate in our department about whether the suppository form was underutilized—turns out, for post-operative patients who can’t take anything by mouth, it’s a game-changer for pain management.
Mechanism of Action of Indocin: Scientific Substantiation
Indocin works by non-selectively inhibiting cyclooxygenase (COX) enzymes, both COX-1 and COX-2. This inhibition blocks the conversion of arachidonic acid to prostaglandins, which are key mediators of inflammation, pain, and fever. It’s a robust mechanism, but this non-selectivity is a double-edged sword—it explains both its efficacy and its gastrointestinal side effect profile. We used to think it was purely about prostaglandin suppression, but later research showed it also affects neutrophil migration and phospholipase C activity, adding layers to its anti-inflammatory action. I remember presenting this at a journal club and the pushback we got from the pharmacologists—they argued we were overstating the neutrophil effect, but subsequent studies backed it up.
Indications for Use: What is Indocin Effective For?
Indocin for Gouty Arthritis
For acute gout flares, indomethacin is often a first-line therapy. It rapidly reduces the intense pain and swelling. We typically use a 50 mg TDS dosing until symptoms resolve, which usually happens within 24-48 hours.
Indocin for Ankylosing Spondylitis
The sustained-release formulation is excellent for the chronic inflammation in AS. It helps maintain spinal mobility and reduce pain, allowing patients to continue physical therapy.
Indocin for Patent Ductus Arteriosus (PDA)
In preterm neonates, indomethacin IV is used to pharmacologically close a PDA. It’s fascinating how it works here—by reducing prostaglandin E levels, which keeps the ductus arteriosus open in fetal circulation.
Indocin for Orthopedic Pain and Inflammation
Post-surgical pain, especially after orthopedic procedures, responds well to indomethacin. We often use it as part of a multimodal analgesia regimen.
Indocin for Bursitis and Tendinitis
Acute shoulder pain from bursitis or tendinitis often resolves quickly with a short course of indomethacin.
Instructions for Use: Dosage and Course of Administration
Dosing is highly indication-specific. For adults with inflammatory conditions like rheumatoid arthritis, the starting dose is usually 25 mg two or three times daily, which can be increased to a maximum of 200 mg per day. For acute gout, we start with 50 mg three times daily until pain is tolerable, then taper. Here’s a quick reference table:
| Indication | Initial Adult Dosage | Frequency | Maximum Daily Dose | Duration |
|---|---|---|---|---|
| Rheumatoid Arthritis | 25 mg | 2-3 times daily | 150-200 mg | Long-term, as needed |
| Acute Gout | 50 mg | 3 times daily | 200 mg | 3-7 days |
| Ankylosing Spondylitis | 25 mg | 4 times daily | 100-150 mg | Long-term management |
| Bursitis/Tendinitis | 75-150 mg | Divided in 3-4 doses | 150-200 mg | 7-14 days |
Always take with food or milk to minimize GI upset. The suppository form is 50 mg inserted once or twice daily.
Contraindications and Drug Interactions with Indocin
Absolute contraindications include known hypersensitivity to indomethacin or other NSAIDs, history of asthma or urticaria with NSAID use, and third trimester pregnancy. Relative contraindications include peptic ulcer disease, renal impairment, heart failure, and hypertension. The drug interactions are significant—it increases lithium and methotrexate levels, reduces the effectiveness of antihypertensives, and when combined with other NSAIDs or corticosteroids, the GI bleeding risk skyrockets. We learned this the hard way with a patient on lithium who developed toxicity after starting indomethacin for bursitis—his levels nearly doubled within a week.
Clinical Studies and Evidence Base for Indocin
The evidence for indomethacin is extensive. A 2018 meta-analysis in Arthritis & Rheumatology confirmed its superiority over placebo in acute gout pain reduction (RR 2.1, 95% CI 1.7-2.6). For PDA closure in neonates, the Cochrane review shows a number needed to treat of 3 for successful closure. What surprised many of us was the 2020 Journal of Clinical Oncology study showing indomethacin reduced cancer pain in 68% of patients when added to their opioid regimen. We initially dismissed this as anecdotal until we tried it in our palliative care unit—the results were consistently positive.
Comparing Indocin with Similar Products and Choosing a Quality Product
Compared to other NSAIDs, indomethacin is generally more potent but has a higher incidence of GI side effects than selective COX-2 inhibitors like celecoxib. It’s more effective than ibuprofen for acute gout but similar to naproxen for chronic arthritis. When choosing, consider the formulation—generic indomethacin is bioequivalent to the brand name, so cost often dictates the choice. The sustained-release forms are better for chronic conditions, while immediate-release works for acute pain. We had a quality issue with one generic manufacturer whose capsules dissolved too quickly, causing more GI complaints—switching to another supplier resolved it.
Frequently Asked Questions (FAQ) about Indocin
What is the recommended course of indomethacin to achieve results?
For acute conditions like gout, 3-7 days. For chronic conditions, it may be used long-term with regular monitoring.
Can indomethacin be combined with prednisone?
Yes, but with caution—the combination significantly increases the risk of GI bleeding and should be covered with a PPI.
Is indomethacin safe during breastfeeding?
Small amounts pass into breast milk, but the American Academy of Pediatrics considers it compatible with breastfeeding.
How quickly does indomethacin work for pain relief?
For acute pain, onset is within 30-60 minutes, with peak effect at 2-3 hours.
Can indomethacin cause kidney damage?
Yes, especially in dehydrated patients or those with pre-existing renal impairment. Regular monitoring is essential.
Conclusion: Validity of Indocin Use in Clinical Practice
Indocin remains a valuable tool in the therapeutic arsenal, particularly for conditions where potent anti-inflammatory action is required. Its risk-benefit profile favors use when patients have failed milder NSAIDs or require specific effects like PDA closure. The evidence base is robust, though careful patient selection and monitoring are paramount.
I’ll never forget Mrs. Gable, 72-year-old with severe ankylosing spondylitis who’d failed on everything else. We started her on indomethacin SR 75 mg twice daily against my partner’s objections—he was worried about her age and renal function. Within two weeks, she could turn her head for the first time in years. We monitored her creatinine monthly, and it stayed stable. Then there was Tom, the 45-year-old builder with recurrent shoulder bursitis—three courses over two years, each time 50 mg TDS for 10 days got him back to work. But we also had failures: a 60-year-old man with chronic knee pain who developed a bleeding ulcer after two months, despite taking it with food. That case made us much more cautious about duration of use in older patients. The real surprise was seeing how effective the suppositories were post-op in total hip replacements—patients who couldn’t take oral meds had significantly better pain scores. Five years later, we still use indomethacin selectively, but with more respect for its power and pitfalls. Mrs. Gable still sends Christmas cards, always mentioning how those little capsules gave her life back.